Advertisement

Supply Chain

Economic pressures to control the rising cost of medical devices has intensified efforts by providers to make better informed purchasing decisions and elicited demand for better "proof" of product superiority from manufacturers.

Indian drugmaker Aurobindo Pharma will open a facility to manufacture 50 million vaccine doses per year to prepare for its commercial launch of vaccine products in 2018, according to Business Standard.

Advertisement

Zimmer Biomet recently acquired CD Diagnostics, a Claymont, Del.-based diagnostics company that develops immunoassays and biomarker testing.

The race is on to reduce operating expenses while improving hospital service levels, and in that race, supply chain executives have to balance financial and operational objectives in the name of innovation, according to Michelle Robbins, vice president of product…

Advertisement